The Optune device, left, shown with carrying case, connecting cables and electrical arrays that are worn on the patient’s head.
via Novocure GmbH
Electricity has formed the basis of many aspects of the modern world, from providing reliable sources of light to powering home appliances and computers. Now, researchers are studying how electricity can be harnessed as a treatment for certain types of cancer.
Kyle Wang, MD, explained that human cells naturally use electricity to line up certain cellular structures, including materials called mitotic spindles, that are used for cell division and growth. To prevent tumor cells from growing, an alternating electric field can be focused at the tumor to disrupt this process.
Electrical field treatment is being explored for a number of cancers throughout the body, but Wang said it has particularly been pursued as a treatment for glioblastomas, the most aggressive and deadly type of brain tumors. The treatment is delivered through a group of electrical arrays, a configuration of electrodes that looks like a mesh cap worn on the head, called an Optune device.
“These arrays point the electric fields at the area of the brain tumor,” said Wang, a University of Cincinnati Cancer Center member and assistant professor of clinical radiation oncology in the UC College of Medicine. “It’s been shown to actually improve how many people survive this disease.”
There is no set requirement, but Wang said in general patients are advised to wear the Optune device for at least 18 hours a day, with the longer the device is worn correlating with better outcomes. While treatment through Optune devices is not necessarily designed to continue indefinitely, Wang said patients typically continue wearing the device unless it is no longer effective or becomes too cumbersome to wear.
Wang is the site principal investigator of a new clinical trial, called TRIDENT, studying if starting treatment through the Optune device earlier will lead to better outcomes.
The Optune devices are currently approved by the Food and Drug Administration as a treatment for glioblastoma patients following surgery and radiation and at the same time as chemotherapy treatment, typically about three months after initial diagnosis. Wang said patients in previous trials who used the devices lived around 30% to 50% longer compared to patients who did not have the device.
In the TRIDENT trial, half of the patients enrolled will begin using the Optune device at the same time as chemotherapy and half will receive the Optune device at the same time as radiation treatment, approximately two to three months earlier than the current standard of care.
“The idea and the hope is that by having the device earlier, and with it working together with radiation and chemotherapy, it can be even more effective than it was proven to be after radiation,” Wang said.
Treatment through the Optune device does not come with any of the typical side effects associated with radiation and chemotherapy treatment, Wang noted, with the most common side effects reported being skin irritation and logistical difficulties.
“It takes a lot of care to figure out how to wear something 18 hours a day that has to plug in to a portable electric source, but every patient that uses the Optune device gets a designated device specialist who makes sure they have almost 24/7 access to questions about how to use this device, how to bring it with them on trips and how to continue living well using this device that’s been shown to improve survival,” he said.
Out of 129 study locations around the world enrolling patients in the TRIDENT study, Wang said UC has been one of the leading enrollers of patients thus far. UC has enrolled 13 patients to date, with the overall study planning to enroll a total of 950 patients.
“Here at the University of Cincinnati, we have a lot of experience both with this device and this trial,” Wang said.
Wang said it is exciting to be at the forefront of a potential treatment for a disease that has been challenging to treat for many years.
“It’s been a long time since something was invented that works for this type of disease,” Wang said. “It’s really fulfilling to have patients that are looking for other options or basically reasons to have hope. I think this trial as well as the device is one of the more impactful discoveries for glioblastoma in decades.”
Original Article: Using electricity to treat cancer
More from: University of Cincinnati
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Electrical field treatment
- Saint Agnes first in Central Valley to use ‘FARAPULSE’ for heart treatments
Fresno-based Saint Agnes announced they are the first hospital in the Central Valley to perform a procedure utilizing the “FARAPULSE™ Pulsed Field Ablation (PFA) System” – designed to treat heart ...
- Ibogaine By David Dardashti Pioneers Work on Quantum Electrodynamics Prototype
MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Ibogaine by David Dardashti looks to revolutionize the field of ibogaine addiction ... a prototype to measure the electric activity inside the brain in order to ...
- Catawba Valley Medical Center unveils new device to treat irregular heart rates
CVMC leadership said the procedure more specifically targets the tissue creating the irregularity and leaves healthy tissue intact and healthy.
- Short electric pulses show promise for enhancing gene therapy
Electrical engineering researchers at the University of Wisconsin–Madison have developed a stimulating method that could make the human body more receptive to certain gene therapies.
- Electric pulses boost gene therapy uptake in liver cells
In an effort to improve delivery of costly medical treatments, a team of researchers in electrical engineering at the University of Wisconsin–Madison has developed a stimulating method that could make ...
Go deeper with Google Headlines on:
Electrical field treatment
[google_news title=”” keyword=”electrical field treatment” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Optune device
- How to Use Apple Managed Device Attestation to secure networks
Managed Device Attestation enables enterprises to verify Apple devices for security, protecting the corporate network. Here's how to use it. In our interconnected world, the issue of device ...
- How to find out what devices are logged into your iCloud account
Want to know every device that’s logged into your iCloud account? It’s a breeze to find out–and may assuage any fears you have that someone has tapped into your accounts. In these uncertain ...
- The best at-home microcurrent devices to lift and firm skin, according to experts
While a regular visit to an aesthetician or dermatologist for a treatment might not be in the cards, the best microcurrent devices offer a way to smooth, lift and firm skin — all without having ...
- Android Find My Device: what is the new tracker network and how does it work?
Google's Find My Device network for Android devices just got a massive upgrade, with the tech giant's "all-new" system for finding lost devices rolling out worldwide from April 8, starting with ...
- What is Google Find My Device and how do I use it?
Google’s Find My Device network received a major boost in 2024, bringing the power of crowdsourced data to the device location service. But what has changed, how does it work, and how do you use it?
Go deeper with Google Headlines on:
Optune device
[google_news title=”” keyword=”Optune device” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]